In Pharma Sustainability, AstraZeneca, Johnson & Johnson Rate High
On a scale of 1 to 100, AstraZeneca and Johnson & Johnson are the only pharmaceutical companies to rate above 70 in a recent survey of sustainability practices in the sector.
Other firms scoring highly are Baxter (66) and GlaxoSmithKline, Pfizer and Schering-Plough, all three of which scored 60.
Climate Counts evaluates firms’ commitments in four areas:
- whether they have measured their carbon footprint
- if they reduced their impact on global warming
- if they have supported or blocked climate legislation or policy
- to what level they have publicly disclosed their climate actions
AstraZeneca scored highly in all sectors except for policy, in which it scored a zero out of ten.
Johnson & Johnson scored highly in all sectors except for measuring its own carbon footprint, an area in which it scored 12 out of 22.
Energy Manager News
- SWL&P Looks to Increase Electric Revenues by Over $2 Million
- Behind the Meter Podcast: A New Metric for Data Center Cooling
- Schneider Electric’s NEO Network: Helping Make Efficiency Projects Real
- Efficiency Project Complete in Meriden, CT
- BuildingIQ Makes 2 Moves
- Constellation Acquiring Retail Electricity, Natural Gas Businesses from ConEdison Solutions
- Peninsula Clean Energy Authority Chooses Direct Energy as Supplier
- Energy Efficiency is Growing on Farms